Factors associated with delayed gastric emptying in patients with stent placement for malignant gastric outlet obstruction

Background and study aims: Delayed gastric emptying (DGE) is an important factor in determining the clinical outcome in patients with stent placement for malignant gastric outlet obstruction but the factors associated with DGE remain unclear. The aim of this study was to investigate whether clinicopathologic data could be used to identify the factors for DGE in such patients.

Patients and methods: A prospective, single-arm, observational clinical study was performed in a referral hospital in Japan. A total of 54 patients with stent placement for malignant gastric outlet obstruction were enrolled. A gastric emptying scintigraphy test was performed 1 week after stent placement. The relationship between DGE and clinicopathologic factors was investigated, and also the relationship between DGE and stent patency time, eating period (when the patient was able to maintain oral intake), and survival time.

Results: A total of 38.9 % (21 /54) of patients had DGE. The following were identified as independent predictive factors of DGE: opioid use (odds ratio, 5.32; 95 % confidence interval [95 %CI], 1.07 – 26.41; p = 0.04), chemotherapy before stent placement (odds ratio, 8.03; 95 %CI, 1.85 – 34.95; p = 0.006), and smaller stent diameter (odds ratio, 13.59; 95 %CI, 1.72 – 107.41; p = 0.01). No relationship was found between DGE and the level of oral intake, stent patency time, eating period, and survival time.

Conclusions: The factors associated with DGE after stent placement include those associated with the patient’s tumor as well as factors relating to their treatment, including stenting. The clinical and functional results after stent placement appear to be unrelated to the gastric emptying findings.

• References

• 1 Jeurnink SM, Steyerberg EW, van Hooft JE et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71: 490-499 PubMed
• 2 Fukami N, Anderson MA, Khan K et al. The role of endoscopy in gastroduodenal obstruction and gastroparesis. Gastrointest Endosc 2011; 74: 13-21 PubMed
• 3 Dormann A, Meisner S, Verin N et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36: 543-550
• 4 Kim JH, Song HY, Shin JH et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007; 66: 256-264 PubMed
• 5 Maetani I, Isayama H, Mizumoto Y. Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study. Gastrointest Endosc 2007; 66: 355-360 PubMed
• 6 van Hooft JE, Uitdehaag MJ, Bruno MJ et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc 2009; 69: 1059-1066 PubMed
• 7 Piesman M, Kozarek RA, Brandabur JJ et al. Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol 2009; 104: 2404-2411 PubMed
• 8 Kim CG, Choi IJ, Lee JY et al. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc 2010; 72: 25-32 PubMed
• 9 van Hooft JE, van Montfoort ML, Jeurnink SM et al. Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study. Endoscopy 2011; 43: 671-675 PubMed
• 10 Costamagna G, Tringali A, Spicak J et al. Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry. Dig Liver Dis 2012; 44: 37-43 PubMed
• 11 Larssen L, Medhus AW, Hauge T. Treatment of malignant gastric outlet obstruction with stents: an evaluation of the reported variables for clinical outcome. BMC Gastroenterol 2009; 9: 45 PubMed
• 12 Larssen L, Hauge T, Medhus AW. Stent treatment of malignant gastric outlet obstruction: the effect on rate of gastric emptying, symptoms, and survival. Surg Endosc 2012; 26: 2955-2960 PubMed
• 13 Parkman HP. Scintigraphy for evaluation of patients for GI motility disorders—the referring physician’s perspective. Semin Nucl Med 2012; 42: 76-78 PubMed
• 14 Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103: 753-763 PubMed
• 15 Maetani I, Ukita T, Tada T et al. Gastric emptying in patients with palliative stenting for malignant gastric outlet obstruction. Hepatogastroenterology 2008; 55: 298-302 PubMed
• 16 Sobin LH, Wittekind C editors. International Union Against Cancer (UICC), TNM classification of malignant tumours. 6th edn New York: Wiley-Liss; 2002
• 17 Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002; 97: 72-78 PubMed
• 18 Cotton PB, Eisen GM, Aabakken L et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454 PubMed
• 19 Maetani I, Tada T, Shimura J et al. Technical modifications and strategies for stenting gastric outlet strictures using esophageal endoprostheses. Endoscopy 2002; 34: 402-406 PubMed
• 20 House A, Champion MC, Chamberlain M. National survey of radionuclide gastric emptying studies. Can J Gastroenterol 1997; 11: 317-321 PubMed
• 21 Adler DG. Enteral stents for malignant gastric outlet obstruction: testing our mettle. Gastrointest Endosc 2007; 66: 361-363 PubMed
• 22 Tougas G, Eaker EY, Abell TL et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-1462 PubMed
• 23 Kim CG, Park SR, Choi IJ et al. Effect of chemotherapy on the outcome of self-expandable metallic stents in gastric cancer patients with malignant outlet obstruction. Endoscopy 2012; 44: 807-812 PubMed
• 24 Canena JM, Lagos AC, Marques IN et al. Oral intake throughout the patients’ lives after palliative metallic stent placement for malignant gastroduodenal obstruction: a retrospective multicentre study. Eur J Gastroenterol Hepatol 2012; 24: 747-755 PubMed
• 25 Guo JP, Maurer AH, Fisher RS et al. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46: 24-29 PubMed
• 26 Pathikonda M, Sachdeva P, Malhotra N et al. Gastric emptying scintigraphy: is four hours necessary?. J Clin Gastroenterol 2012; 46: 209-215 PubMed
• 27 Choi MG, Camilleri M, Burton DD et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998; 93: 92-98 PubMed
• 28 De Schepper HU, Cremonini F, Park MI et al. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004; 16: 383-394 PubMed
• 29 Donthireddy KR, Ailawadhi S, Nasser E et al. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 2007; 5: 355-363 PubMed
• 30 Mendelsohn RB, Gerdes H, Markowitz AJ et al. Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc 2011; 73: 1135-1140 PubMed